Warburg-Backed Hong Kong Firm That Uses AI for Drug Discovery Files for U.S. IPO

Insilico Medicine, a Hong Kong-based company that uses artificial intelligence to drive drug discovery, filed confidentially for a U.S. initial public offering last week, according to people familiar …
( read original story …)

---